Food and Drug Administration

Center for Drug Evaluation and Research

 

Arthritis Advisory Committee

Silver Spring Holiday Inn, 8777 Georgia Avenue, Silver Spring, MD

 

Open Public Hearing

  March 5, 2003

 

NDA: 20-905, ARAVAÔ,  (leflunomide), Aventis Pharmaceuticals Inc.

 

 

 

1. Sidney M. Wolfe, MD, Director,  Public Citizen Health Research Group

 

2. Kevin Brennan, Senior Vice President, Health Policy, Arthritis Foundation

 

3. Amye Leong, Spokesperson: United Nations Endorsed Bone and Joint Decade